184 related articles for article (PubMed ID: 23020091)
1. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
Fan D; Wu X; Dong W; Sun W; Li J; Tang X
Drug Dev Ind Pharm; 2013 Sep; 39(9):1447-56. PubMed ID: 23020091
[TBL] [Abstract][Full Text] [Related]
2. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
3. Increased absorption of mangiferin in the gastrointestinal tract and its mechanism of action by absorption enhancers in rats.
Wang X; Gu Y; Ren T; Tian B; Zhang Y; Meng L; Tang X
Drug Dev Ind Pharm; 2013 Sep; 39(9):1408-13. PubMed ID: 22816369
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
Lv XY; Li J; Zhang M; Wang CM; Fan Z; Wang CY; Chen L
AAPS PharmSciTech; 2010 Mar; 11(1):372-82. PubMed ID: 20237966
[TBL] [Abstract][Full Text] [Related]
5. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption of raltitrexed and evaluation of the effects of absorption enhancers.
Yu Y; Lu Y; Zhao X; Li X; Yin Z
Pharmazie; 2013 Sep; 68(9):732-43. PubMed ID: 24147341
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Chen W; Fan D; Meng L; Miao Y; Yang S; Weng Y; He H; Tang X
Drug Dev Ind Pharm; 2012 Jan; 38(1):104-10. PubMed ID: 21774632
[TBL] [Abstract][Full Text] [Related]
8. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.
Maher S; Wang X; Bzik V; McClean S; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):301-11. PubMed ID: 19664704
[TBL] [Abstract][Full Text] [Related]
10. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
11. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
12. Increased systemic exposure to rhizoma coptidis alkaloids in lipopolysaccharide-pretreated rats attributable to enhanced intestinal absorption.
Ma BL; Yao MK; Zhong J; Ma YM; Gao CL; Wu JS; Qiu FR; Wang CH; Wang XH
Drug Metab Dispos; 2012 Feb; 40(2):381-8. PubMed ID: 22086980
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine.
Shi C; Tong Q; Fang J; Wang C; Wu J; Wang W
Eur J Pharm Sci; 2015 Jul; 74():11-7. PubMed ID: 25861719
[TBL] [Abstract][Full Text] [Related]
14. Novel cremochylomicrons for improved oral bioavailability of the antineoplastic phytomedicine berberine chloride: Optimization and pharmacokinetics.
Elsheikh MA; Elnaggar YSR; Hamdy DA; Abdallah OY
Int J Pharm; 2018 Jan; 535(1-2):316-324. PubMed ID: 29138046
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
17. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology.
Chao AC; Nguyen JV; Broughall M; Griffin A; Fix JA; Daddona PE
Int J Pharm; 1999 Nov; 191(1):15-24. PubMed ID: 10556736
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
20. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Jin S; Fu S; Han J; Jin S; Lv Q; Lu Y; Qi J; Wu W; Yuan H
J Drug Target; 2012 Aug; 20(7):615-22. PubMed ID: 22726209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]